Structure of Rocaglamide
CAS No.: 84573-16-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Rocaglamide (Roc-A), isolated from the genus Aglaia, is used for treating coughs, injuries, asthma, and inflammatory skin diseases. Rocaglamide is a potent inhibitor of NF-κB activation in T-cells and a selective inhibitor of heat shock factor 1 (HSF1) activation with an IC50 of ~50 nM. It also inhibits the function of the translation initiation factor eIF4A and has anticancer properties in leukemia.
Synonyms: Roc-A; NSC 326408; Rocaglamide A
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 84573-16-0 |
Formula : | C29H31NO7 |
M.W : | 505.56 |
SMILES Code : | O=C([C@H]([C@H]1C2=CC=CC=C2)[C@@H](O)[C@]3(O)[C@@]1(C4=CC=C(OC)C=C4)OC5=CC(OC)=CC(OC)=C35)N(C)C |
Synonyms : |
Roc-A; NSC 326408; Rocaglamide A
|
MDL No. : | MFCD08702699 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Description |
Rocaglamide (Roc-A), sourced from the Aglaia genus, is utilized for various ailments like coughs, injuries, asthma, and inflammatory skin disorders. It is a potent inhibitor of NF-κB activation in T-cells, a significant and selective suppressor of heat shock factor 1 (HSF1) activation with an IC50 value close to 50 nM, restricts the function of the translation initiation factor eIF4A, and exhibits anticancer effects, particularly against leukemia[1].[2].[3].
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
healthy peripheral blood T cells | 100 nM | 16 hours | Roc-AR does not sensitize healthy T cells to CD95L and TRAIL-induced apoptosis | PMC3131883 |
HeLa cells | 50 nM | 24 hours | FL3 treatment potently inhibited PINK1-PRKN-mediated mitophagy, blocking the recruitment and accumulation of PRKN and PINK1 on mitochondria | PMC6999623 |
HCT116 cells | 50 nM | 24 hours | FL3 or Roc-A treatment markedly increased the protein level of PARL but had no effect on the protein levels of PHB and PHB2 | PMC6999623 |
H460 cells | 0, 31.25, 62.5, 125, 250 and 500 nM | 24 hours | To evaluate the effect of RocA on NK cell-mediated lysis of H460 cells, results showed that RocA enhanced NK cell-mediated lysis of H460 cells. | PMC6135631 |
H1975 cells | 250 nM | 24 hours | To evaluate the effect of RocA on NK cell-mediated lysis of H1975 cells, results showed that RocA enhanced NK cell-mediated lysis of H1975 cells. | PMC6135631 |
A549 cells | 250 nM | 24 hours | To evaluate the effect of RocA on NK cell-mediated lysis of A549 cells, results showed that RocA enhanced NK cell-mediated lysis of A549 cells. | PMC6135631 |
A549 cells | 12.5 nM and 25 nM | 24 hours | RocA significantly increased the expression of CCL5 in A549 cells | PMC8741839 |
H1299 cells | 12.5 nM and 25 nM | 24 hours | RocA significantly increased the expression of CCL5 in H1299 cells | PMC8741839 |
H1975 cells | 12.5 nM and 25 nM | 24 hours | RocA significantly increased the expression of CCL5 in H1975 cells | PMC8741839 |
LLC cells | 25 nM and 50 nM | 24 hours | RocA significantly increased the expression of CXCL10 in LLC cells | PMC8741839 |
U87MG | 6.25 nM | 24 hours | To investigate the effects of Rocaglamide on the translation machinery and protein output in U87MG cells, it was found that it induced the expression of specific proteins and activated the JNK signaling pathway. | PMC8558842 |
Human peripheral blood T lymphocytes | 75 nM | 24 hours | Roc-A significantly reduced apoptosis in T cells induced by DNA-damaging anticancer drugs, with a dose-dependent protective effect. | PMC4040689 |
Human peripheral blood B cells | 75 nM | 24 hours | Roc-A significantly reduced apoptosis in B cells induced by Etoposide. | PMC4040689 |
Human peripheral blood NK cells | 75 nM | 24 hours | Roc-A significantly reduced apoptosis in NK cells induced by Etoposide. | PMC4040689 |
Human neutrophils | 75 nM | 24 hours | Roc-A significantly reduced apoptosis in neutrophils induced by Etoposide. | PMC4040689 |
Human cardiomyocytes | 75 nM | 24 hours | Roc-A significantly reduced apoptosis in cardiomyocytes induced by Etoposide. | PMC4040689 |
Murine hematopoietic stem and progenitor cells | 75 nM | 24 hours | Roc-A significantly reduced apoptosis in murine hematopoietic stem and progenitor cells induced by Etoposide. | PMC4040689 |
HEK 293 cells | 30 nM | 30 minutes | RocA treatment caused a dose-dependent decrease in polysome formation and protein synthesis, inhibiting translation without causing 4EBP dephosphorylation or eIF2α phosphorylation, but partially rescued by expression of RocA-resistant eIF4A proteins. | PMC4946961 |
HEK293 cells | 0.3 µM, 3 µM | 30 minutes | To investigate the perturbation of translation elongation dynamics by RocA, it was found that RocA selectively perturbed the early translation elongation of a set of genes, leading to ribosome collision and reduction of protein synthesis. | PMC9891901 |
HEK293 cells | 0.3 μM | 30 minutes | To evaluate the effect of RocA on translation in HEK293 cells using ribosome profiling, results showed that RocA significantly inhibited the translation of specific mRNAs. | PMC6386617 |
HTLV-1-associated ATL cell lines (SP, MT-2, CHAMP, ATL-3) | 100 nM | 4 hours | Roc-AR inhibits c-FLIP expression and enhances TRAIL and CD95L-induced apoptosis | PMC3131883 |
SP cells | 100 nM | 4 hours | Roc-AR inhibits c-FLIP expression and enhances TRAIL- and CD95L-induced apoptosis | PMC3131883 |
CHAMP cells | 100 nM | 4 hours | Roc-AR inhibits c-FLIP expression and enhances TRAIL- and CD95L-induced apoptosis | PMC3131883 |
M9-ENL cell line | 40nM | 48 hours | Rocaglamide was significantly more cytotoxic to leukemia cells compared to other translation inhibitors such as Temsirolimus. | PMC4148474 |
HEK293 cells | 0-10 nM | 72 hours | To assess the effect of RocA on the viability of HEK293 cells, results showed that RocA significantly inhibited cell viability at low concentrations. | PMC6386617 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
SCID/Bg mice | H1975 cell subcutaneous xenograft tumor model | Intraperitoneal injection | 0.3 mg/kg | Every 2 days, until day 21 | To evaluate the inhibitory effect of RocA on H1975 cell subcutaneous xenograft tumors, results showed that RocA significantly inhibited tumor growth. | PMC6135631 |
Mice | Foxp3DTR mice | Intraperitoneal injection | 0.2 mg/kg | Once daily for 8 days | To test whether RocA could alleviate inflammation caused by Treg depletion, results showed that RocA significantly reduced weight loss and decreased the number of splenic CD4 T cells producing IL-17A or IFNγ. | PMC9827529 |
C57BL/6 mice | LLC cell subcutaneous xenograft model | intraperitoneal injection | 1.0 mg/kg | every 2 days for 18 days | RocA significantly increased the infiltration of NK cells in tumors and inhibited tumor growth | PMC8741839 |
Mice | Patient-derived xenograft model | Intraperitoneal injection | 1 mg/kg | Once daily for 3 days | To investigate the effects of Rocaglamide on tumors in vivo, it was found that it induced GEF-H1 protein expression and JNK phosphorylation, leading to tumor cell death. | PMC8558842 |
Tags: Rocaglamide | Roc-A | NF-κB | HSP | Eukaryotic Initiation Factor (eIF) | Nuclear factor-κB | Nuclear factor-kappaB | Heat shock proteins | NF-κB inhibition | HSF1 activation | eIF4A inhibitor | heat shock factor 1 | HSF1 activation | Aglaia compound | 84573-16-0
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL